years of innovations in fusion technology.
of clinicians who saw the new EPIQ CVxi thought the EPIQ MultiVue real-time alignment solution could help to reduce the risk of choosing an incorrectly sized device during interventional procedures[2].
Treat one more patient per day, by reducing procedure time by 17%* with the optimized workflow options and clinical software of Azurion.
Reorient and combine ultrasound and X-ray into a single augmented visualization.
Premium interventional cardiology ultrasound system with powerful AI-based capabilities and nSight imaging to help you transcend today's complexities and propel interventional echocardiography into the next dimension.
*Reducing procedure time by 17%, with the ability to treat 1 more patient per day with optimized workflow options in image guided therapy and clinical software (Azurion - Philips Azurion Simulation Study 2016 - 12NC 452299123041 - FEB 2017). Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. [1] Afzal, S., et al., First experience with real-time 3D anatomical fusion imaging during left atrial appendage occluder implantation. Eur Heart J Cardiovasc Imaging, 2017. 18(6): p. 719-720.This claim is based on a single center study with limited number of patients. This claim is limited to mitral clipping and left atrial appendage occlusion. [2] Jungen et al., PLoS One 2015 Oct 14;10(10); Left Atrial Appendage Closure Guided by Integrated Echocardiography and Fluoroscopy Imaging Reduces Radiation Exposure. Please note that not all products displayed on our website may be available in your country due to varying local regulations and market conditions. For the most accurate availability information, please contact your local representative.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.